Contact information
Type
Scientific
Primary contact
Dr Gerhard Gmel
ORCID ID
Contact details
Mont Paisible 16
Lausanne
1011
Switzerland
gerhard.gmel@chuv.ch
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
FOllow-up and Brief Intervention of Conscripts in Lausanne, Switzerland: a single-centre randomised controlled trial
Acronym
FOBIC
Study hypothesis
Testing the effectiveness of brief interventions on alcohol, tobacco, and cannabis use and related risks outside a clinical setting and delivering it to a large majority of men in the French speaking region of Switzerland. A first phase will concentrate on alcohol use intervention, a second on tobacco, and a third on all substances addressed together.
Research questions are:
1. Are brief interventions among young men effective in reducing hazardous alcohol use and substance use in general?
2. Are booster sessions more effective than single brief intervention sessions?
3. Does a brief intervention in one domain (e.g., alcohol) show cross-effects in another domain (e.g., tobacco)?
4. Are interventions simultaneously provided for multiple risks more effective than an intervention focusing on one risk behaviour at the time?
5. Can simple assessment of problematic use (without brief motivational interviewing [BMI]) be seen as an effective minimal intervention? This can be demonstrated by comparing conscripts of the randomised trial that received
5.1. BMI with those who did not receive BMI but for which substance use was measured during assessment, and
5.2. By comparing the assessment only group with a second control group that received only screening without further assessment and without BMI
As of 13/02/2009 this record was updated to include amended trial dates; the initial trial dates at the time of registration were as follows:
Initial anticipated start date: 30/01/2007
Initial anticipated end date: 31/12/2010
Ethics approval
Added 13/02/09: Ethics Committee for Clinical Research of the Lausanne University Medical School gave approval on the 2nd April 2007 (ref: 15/07)
Study design
Single-centre randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Hospitals
Trial type
Treatment
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Alcohol, tobacco, and cannabis use
Intervention
This trial comprises three separate studies:
1. Study on alcohol use (600 participants)
2. Study on tobacco use (600 participants)
3. Study on the use of alcohol, tobacco and cannabis assessed together (600 participants)
Within each study, the participants will be allocated to one of the following three groups:
Group 1: Screening only (200 participants)
Group 2: Screening + assessment (200 participants)
Group 3: Screening + assessment + BMI (200 participants)
The screening questionnaire takes approximately 5 minutes to complete. The assessment questionnaire takes approximately 15 minutes to complete. BMI is intended to enforce the motivation to change behaviour. Interventions are conducted by experienced psychologists trained in motivational interviewing and in providing brief motivational interventions. Interventions last approximately 30 minutes. The same psychologists provide booster brief motivational intervention sessions 3 months after the first session by telephone. Booster sessions last approximately 20 minutes. Follow-up will be carried out at 6 months.
Intervention type
Other
Phase
Not Applicable
Drug names
Primary outcome measures
Alcohol, tobacco and cannabis use 6 months after baseline, measured by the following:
1. Alcohol use:
1.1. Quantity/frequency questionnaires
1.2. Retrospective diary
1.3. Alcohol Use Disorder Identification Test
2. Tobacco use:
2.1. Quantity/frequency questionnaires
2.2. Cigarette Dependence Scale
3. Cannabis use:
3.1. First three questions of the Cannabis Use Disorder Identification Test
Secondary outcome measures
1. Reduction of related risks 6 months after baseline. Related risks are measured using several tests:
1.1. Wechsler Alcohol Consequences
1.2. Questionnaire on dinking and driving
1.3. Attitudes Towards Smoking Scale, or questionnaire for cannabis use consequences
2. Cross-over effects:
2.1. Reduction in at-risk use of tobacco and cannabis use during the alcohol study at 6 months after baseline
2.2. Reduction in at-risk use of alcohol and cannabis use during the tobacco phase at 6 months after baseline.
2.3. Substance use, measured as described above
3. Readiness to change at 6 months after baseline, measured using 10-points Visual Analogue Scale (1 = not ready to change, 10 = extremely ready to change)
Overall trial start date
30/01/2007
Overall trial end date
31/12/2010
Reason abandoned
Eligibility
Participant inclusion criteria
1. 19-year old males with a Swiss citizenship enrolling during the mandatory army recruitment process in the French-speaking part of Switzerland
2. Informed consent
3. Provision of a contact address
Participant type
Patient
Age group
Adult
Gender
Male
Target number of participants
1,800 participants. Target number of recruitment may be increased if additional funding becomes available.
Participant exclusion criteria
Lack of informed consent and provision of contact address.
Recruitment start date
30/01/2007
Recruitment end date
31/12/2010
Locations
Countries of recruitment
Switzerland
Trial participating centre
Mont Paisible 16
Lausanne
1011
Switzerland
Sponsor information
Organisation
Swiss Alcohol Research Foundation (Fondation Suisse De Recherche Sur L'alcool) (Switzerland)
Sponsor details
Case postale 870
Lausanne
1001
Switzerland
+41 21 321 29 59
edomengevieu@sfa-ispa.ch
Sponsor type
Research organisation
Website
Funders
Funder type
Research organisation
Funder name
Swiss Foundation for Alcohol Research (Switzerland) - funding for the alcohol study phase
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Funder name
Swiss Tobacco Prevention Funds (Switzerland) - funding obtained in 2008 for the tobacco study phase
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Funder name
Swiss National Science Foundation (Switzerland) - application to be submitted in 2010 for the funding of the multi-substance study phase
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary
1. 2008 findings of the screening porcedure in http://www.ncbi.nlm.nih.gov/pubmed/18723839
2. 2008 pilot phase results in http://www.saphirdoc.ch/permalien.htm?saphirid=70538
3. 2013 results in http://www.ncbi.nlm.nih.gov/pubmed/22931392
Publication citations
-
Findings of the screening porcedure
Gmel G, Gaume J, Faouzi M, Kulling JP, Daeppen JB, Who drinks most of the total alcohol in young men--risky single occasion drinking as normative behaviour., Alcohol Alcohol., 43, 6, 692-697, doi: 10.1093/alcalc/agn070.
-
Results
Bertholet N, Gaume J, Faouzi M, Gmel G, Daeppen JB, Predictive value of readiness, importance, and confidence in ability to change drinking and smoking., BMC Public Health, 2012, 12, 708, doi: 10.1186/1471-2458-12-708.